PMID: 24069370
22.2 min, 100% B, all at a flow rate of 150 l min 1 , followed by 22.7 min, 100% B
(2026) Funding This study was supported by the National Key R&D Program of China (2024YFC3505800), the Natural Science Foundation of Shandong Province of China (ZR2023MH112), the National Natural Science Foundation of China (82474560)
In REDEFINE 1 , a 68-week, Phase 3a, multicenter, double-blind, placebo- and active-controlled trial, 3,417 adults with overweight or obesity but without diabetes were randomized to CagriSema (cagrilintide 2.4 mg + semaglutide 2.4 mg), semaglutide 2.4 mg, cagrilintide 2.4 mg, or placebo
Ching, J
A1 casein might stimulate inflammatory chemicals and worsen digestive distress